No correlation between androgen receptor CAG and GGN repeat length and the degree of genital virilization in females with 21-hydroxylase deficiency

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 5, 2010, Pages 2443-2450

  Welzel, M ^a   Schwarz, H P ^b   Hedderich, J ^a   Dorr H G ^d   Binder, G ^e   Bramswig J H ^f   Krude, H ^g   Richter Unruh, A ^h   Niedziela, M ⁱ   Gromoll, J ^j   Krone, N ^c   Riepe, F G ^a   Holterhus, Paul Martin ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^e UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^f UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^g CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^h Endokrinologikum Ruhr   (Germany)

ⁱ POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^j UNIVERSITY OF MÜNSTER   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; STEROID 21 MONOOXYGENASE; CYP21A2 PROTEIN, HUMAN; PRIMER DNA;

ARTICLE; CAG REPEAT; CONTROLLED STUDY; DISEASE CLASSIFICATION; DNA MODIFICATION; DNA STRUCTURE; FEMALE; GENE MUTATION; GENETIC CORRELATION; GENETIC POLYMORPHISM; GENOTYPE; GGN REPEAT; HUMAN; MAJOR CLINICAL STUDY; NULL ALLELE; PRIORITY JOURNAL; RECEPTOR GENE; STEROID 21 MONOOXYGENASE DEFICIENCY; TRINUCLEOTIDE REPEAT; VIRILIZATION; ALLELE; CLASSIFICATION; CONGENITAL ADRENAL HYPERPLASIA; GENE AMPLIFICATION; GENE DELETION; GENETICS; GONADAL DISEASE; PATHOLOGY; POLYMERASE CHAIN REACTION;

ADRENAL HYPERPLASIA, CONGENITAL; ALLELES; DNA PRIMERS; FEMALE; GENE AMPLIFICATION; GENOTYPE; HUMANS; POLYMERASE CHAIN REACTION; RECEPTORS, ANDROGEN; SEQUENCE DELETION; STEROID 21-HYDROXYLASE; TRINUCLEOTIDE REPEATS; VIRILISM;

EID: 77952761898     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-1338     Document Type: Article

References (33)

1. White PC, Speiser PW 2000 Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 21:245-291 (Pubitemid 32275589)
2. Prader A 1954 Genital findings in the female pseudo-hermaphroditism of the congenital adrenogenital syndrome; morphology, frequency, development and heredity of the different genital forms. Helv Paediatr Acta 9:231-248
3. Speiser PW, Dupont J, Zhu D, Serrat J, Buegeleisen M, Tusie-Luna MT, Lesser M, New MI, White PC 1992 Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Invest 90:584-595
4. Krone N, Braun A, Roscher AA, Knorr D, Schwarz HP 2000 Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany. J Clin Endocrinol Metab 85:1059-1065
5. Araujo RS, Billerbeck AE, Madureira G, Mendonca BB, Bachega TA 2005 Substitutions in the CYP21A2 promoter explain the simple-virilizing form of 21-hydroxylase deficiency in patients harbouring a P30L mutation. Clin Endocrinol (Oxf) 62:132-136
6. Wedell A, Thilén A, Ritzén EM, Stengler B, Luthman H 1994 Mutational spectrum of the steroid 21-hydroxylase gene in Sweden: implications for genetic diagnosis and association with disease manifestation. J Clin Endocrinol Metab 78:1145-1152
7. Torres N, Mello MP, Germano CM, Elias LL, Moreira AC, Castro M 2003 Phenotype and genotype correlation of the microconversion from the CYP21A1P to the CYP21A2 gene in congenital adrenal hyperplasia. Braz J Med Biol Res 36:1311-1318
8. Dunning AM, McBride S, Gregory J, Durocher F, Foster NA, Healey CS, Smith N, Pharoah PD, Luben RN, Easton DF, Ponder BA 1999 No association between androgen or vitamin D receptor gene polymorphisms and risk of breast cancer. Carcinogenesis 20:2131-2135
9. Mhatre AN, Trifiro MA, Kaufman M, Kazemi-Esfarjani P, Figlewicz D, Rouleau G, Pinsky L 1993 Reduced transcriptional regulatory competence of the androgen receptor in X-linked spinal and bulbar muscular atrophy. Nat Genet 5:184-188 (Pubitemid 23293456)
10. Hardy DO, Scher HI, Bogenreider T, Sabbatini P, Zhang ZF, Nanus DM, Catterall JF 1996 Androgen receptor CAG repeat lengths in prostate cancer: correlation with age of onset. J Clin Endocrinol Metab 81:4400-4405
11. Ellis JA, Stebbing M, Harrap SB 2001 Polymorphism of the androgen receptor gene is associated with male pattern baldness. J Invest Dermatol 116:452-455
12. Ibáñez L, Ong KK, Mongan N, Jääskeläinen J, Marcos MV, Hughes IA, De Zegher F, Dunger DB 2003 Androgen receptor gene CAG repeat polymorphism in the development of ovarian hyperandrogenism. J Clin Endocrinol Metab 88:3333-3338
13. Lappalainen S, Utriainen P, Kuulasmaa T, Voutilainen R, Jääskeläinen J 2008 Androgen receptor gene CAG repeat polymorphism and X-chromosome inactivation in children with premature adrenarche. J Clin Endocrinol Metab 93:1304-1309
14. Zitzmann M, Depenbusch M, Gromoll J, Nieschlag E 2004 X-chromosome inactivation patterns and androgen receptor functionality influence phenotype and social characteristics as well as pharmacogenetics of testosterone therapy in Klinefelter patients. J Clin Endocrinol Metab 89:6208-6217
15. Zinn AR, Ramos P, Elder FF, Kowal K, Samango-Sprouse C, Ross JL 2005 Androgen receptor CAGn repeat length influences phenotype of 47, XXY (Klinefelter) syndrome. J Clin Endocrinol Metab 90:5041-5046
16. Rocha RO, Billerbeck AE, Pinto EM, Melo KF, Lin CJ, Longui CA, Mendonca BB, Bachega TA 2008 The degree of external genitalia virilization in girls with 21-hydroxylase deficiency appears to be influenced by the CAG repeats in the androgen receptor gene. Clin Endocrinol (Oxf) 68:226-232
17. Lundin KB, Giwercman A, Dizeyi N, Giwercman YL 2007 Functional in vitro characterisation of the androgen receptor GGN polymorphism. Mol Cell Endocrinol 264:184-187
18. Werner R, Schütt J, Hannema S, Röpke A, Wieacker P, Hiort O, Holterhus PM 2006 Androgen receptor gene mutations in androgen insensitivity syndrome cause distinct patterns of reduced activation of androgen-responsive promoter constructs. J Steroid Biochem Mol Biol 101:1-10
19. Werner R, Holterhus PM, Binder G, Schwarz HP, Morlot M, Struve D, Marschke C, Hiort O 2006 The A645D mutation in the hinge region of the human androgen receptor (AR) gene modulates AR activity, depending on the context of the polymorphic glutamine and glycine repeats. J Clin Endocrinol Metab 91:3515-3520
20. Lyon MF 2002 X-chromosome inactivation and human genetic disease. Acta Paediatr Suppl 91:107-112 (Pubitemid 36174161)
21. Krone N, Braun A, Weinert S, Peter M, Roscher AA, Partsch CJ, Sippell WG 2002 Multiplex minisequencing of the 21-hydroxylase gene as a rapid strategy to confirm congenital adrenal hyperplasia. Clin Chem 48:818-825
22. Holterhus PM, Brüggenwirth HT, Hiort O, Kleinkauf-Houcken A, Kruse K, Sinnecker GH, Brinkmann AO 1997 Mosaicism due to a somatic mutation of the androgen receptor gene determines phenotype in androgen insensitivity syndrome. J Clin Endocrinol Metab 82:3584-3589
23. Naumova AK, Olien L, Bird LM, Smith M, Verner AE, Leppert M, Morgan K, Sapienza C 1998 Genetic mapping of X-linked loci involved in skewing of X chromosome inactivation in the human. Eur J Hum Genet 6:552-562
24. Vottero A, Stratakis CA, Ghizzoni L, Longui CA, Karl M, Chrousos GP 1999 Androgen receptor-mediated hypersensitivity to androgens in women with nonhyperandrogenic hirsutism: skewing of X-chromosome inactivation. J Clin Endocrinol Metab 84:1091-1095
25. Freedman ML, Pearce CL, Penney KL, Hirschhorn JN, Kolonel LN, Henderson BE, Altshuler D 2005 Systematic evaluation of genetic variation at the androgen receptor locus and risk of prostate cancer in a multiethnic cohort study. Am J Hum Genet 76:82-90
26. Hickey T, Chandy A, Norman RJ 2002 The androgen receptor CAG repeat polymorphism and X-chromosome inactivation in Australian Caucasian women with infertility related to polycystic ovary syndrome. J Clin Endocrinol Metab 87:161-165
27. Ruhayel Y, Lundin K, Giwercman Y, Halldén C, Willén M, Giwercman A 2004 Androgen receptor gene GGN and CAG polymorphisms among severely oligozoospermic and azoospermic Swedish men. Hum Reprod 19:2076-2083
28. Lundin KB, Giwercman YL, Rylander L, Hagmar L, Giwercman A 2006 Androgen receptor gene GGN repeat length and reproductive characteristics in young Swedish men. Eur J Endocrinol 155:347-354 (Pubitemid 44269453)
29. Erenpreiss J, Tsarev I, Giwercman A, Giwercman Y 2008 The impact of androgen receptor polymorphism and parental ethnicity on semen quality in young men from Latvia. Int J Androl 31:477-482
30. Rajender S, Rajani V, Gupta NJ, Chakravarty B, Singh L, Thangaraj K 2006 No association of androgen receptor GGN repeat length polymorphism with infertility in Indian men. J Androl 27:785-789
31. Aschim EL, Nordenskjöld A, Giwercman A, Lundin KB, Ruhayel Y, Haugen TB, Grotmol T, Giwercman YL 2004 Linkage between cryptorchidism, hypospadias, and GGN repeat length in the androgen receptor gene. J Clin Endocrinol Metab 89:5105-5109
32. Huhtaniemi IT, Pye SR, Limer KL, Thomson W, O'Neill TW, Platt H, Payne D, John SL, Jiang M, Boonen S, Borghs H, Vanderschueren D, Adams JE, Ward KA, Bartfai G, Casanueva F, Finn JD, Forti G, Giwercman A, Han TS, Kula K, Lean ME, Pendleton N, Punab M, Silman AJ, Wu FC 2009 Increased estrogen rather than decreased androgen action is associated with longer androgen receptor CAG repeats. J Clin Endocrinol Metab 94:277-284
33. Antonarakis SE 1998 Recommendations for a nomenclature system for human gene mutations. Nomenclature Working Group. Hum Mutat 11:1-3